Oramed Pharmaceuticals Inc.
ORMP
$2.33
$0.031.30%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 141.93M | 142.30M | 152.74M | 176.59M | 162.05M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.29M | 474.00K | 533.00K | 501.00K | 537.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 143.22M | 142.77M | 153.27M | 177.10M | 162.58M |
|
|
|||||
| Total Current Assets | 143.22M | 142.77M | 153.27M | 177.10M | 162.58M |
| Net Property, Plant & Equipment | 1.11M | 1.20M | 1.33M | 1.43M | 1.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 34.00K | 32.00K | 30.00K | 36.00K | 34.00K |
| Total Assets | 155.28M | 165.08M | 184.22M | 203.65M | 220.55M |
|
|
|||||
| Total Accounts Payable | 789.00K | 5.00M | 3.48M | 1.27M | 551.00K |
| Total Accrued Expenses | 1.48M | 35.00K | -- | 1.00K | 1.38M |
| Short-term Debt | -- | -- | -- | 32.03M | 51.01M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 216.00K | 243.00K | 250.00K | 254.00K | 267.00K |
| Total Finance Division Other Current Liabilities | 3.20M | -- | -- | -- | -- |
| Total Other Current Liabilities | 3.20M | -- | -- | -- | -- |
| Total Current Liabilities | 5.69M | 5.27M | 3.73M | 33.56M | 53.21M |
|
|
|||||
| Total Current Liabilities | 5.69M | 5.27M | 3.73M | 33.56M | 53.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 32.03M | 51.01M |
| Capital Leases | 156.00K | 186.00K | 236.00K | 272.00K | 342.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.09M | 4.10M | 4.10M | 4.10M | 4.10M |
| Total Liabilities | 9.93M | 9.56M | 8.07M | 37.93M | 57.66M |
|
|
|||||
| Common Stock & APIC | 322.88M | 322.87M | 323.87M | 322.66M | 321.38M |
| Retained Earnings | -176.62M | -166.43M | -146.81M | -156.02M | -157.56M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 146.27M | 156.44M | 177.07M | 166.64M | 163.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 146.27M | 156.44M | 177.07M | 166.64M | 163.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -918.00K | -919.00K | -911.00K | -918.00K | -928.00K |
| Total Equity | 145.35M | 155.52M | 176.15M | 165.72M | 162.89M |
|
|
|||||